Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
New Ray Medicine International Holding Ltd. ( (HK:6108) ) has shared an update.
New Ray Medicine International Holding Limited plans to overhaul its constitutional documents by adopting a new set of bye-laws that align with the latest Hong Kong Listing Rules and the forthcoming Uncertificated Securities Market framework. The move will allow shareholders to hold and transfer company shares in uncertificated form while also incorporating various housekeeping amendments to modernise governance.
The proposed new bye-laws will replace the existing version and are subject to approval by shareholders via a special resolution at the upcoming annual general meeting. The company will circulate a detailed circular and AGM notice in due course, and, based on current information, no shareholders are required to abstain from voting on the adoption of the new governance framework.
More about New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Limited is a Bermuda-incorporated company listed on the Main Board of the Hong Kong Stock Exchange under stock code 6108. The group operates in the pharmaceutical sector, with its business focused on medicine-related products and services within Greater China, leveraging Hong Kong listing rules and market infrastructure for capital access.
Average Trading Volume: 228,339
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$41.13M
Find detailed analytics on 6108 stock on TipRanks’ Stock Analysis page.